Epitope spreading as an early pathogenic event in pediatric multiple sclerosis

Neurology

Volumn 83, Issue 24, 2014, Pages 2219-2226

  Quintana, Francisco J ^a   Patel, Bonny ^a   Yeste, Ada ^a   Nyirenda, Mukanthu ^b   Kenison, Jessica ^a   Rahbari, Roya ^a   Fetco, Dumitru ^c   Hussain, Mohammad ^a   O'Mahony, Julia ^d,e   Magalhaes, Sandra ^b   McGowan, Melissa ^d   Johnson, Trina ^b   Rajasekharan, Sathy ^b   Narayanan, Sridar ^c   Arnold, Douglas L ^c   Weiner, Howard L ^a   Banwell, Brenda ^d,f   Bar Or, Amit ^b  

^a Brigham and Women's Hospital Center for Neurologic Diseases   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; MYELIN; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROTEIN ANTIBODY; PROTEOLIPID PROTEIN; AUTOANTIBODY; AUTOANTIGEN;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIGEN DETECTION; AREA UNDER THE CURVE; ARTICLE; CHILD; CHILDHOOD DISEASE; DEMYELINATING DISEASE; FEMALE; FOLLOW UP; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN MICROARRAY; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; BLOOD; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; COMPARATIVE STUDY; DEMYELINATING DISEASES; DISEASE COURSE; IMMUNOLOGY; MICROARRAY ANALYSIS; PATHOLOGY;

ADOLESCENT; AUTOANTIBODIES; AUTOANTIGENS; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; DEMYELINATING DISEASES; DISEASE PROGRESSION; EPITOPES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; MALE; MICROARRAY ANALYSIS; MULTIPLE SCLEROSIS; PROSPECTIVE STUDIES; ROC CURVE;

EID: 84925938846     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001066     Document Type: Article

References (28)

1. Banwell B, Ghezzi A, Bar-Or A, Mikaeloff Y, Tardieu M. Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol 2007;6: 887-902.
2. Yeh EA, Chitnis T, Krupp L, et al. Pediatric multiple sclerosis. Nat Rev Neurol 2009;5:621-631.
3. Verhey LH, Branson HM, Shroff MM, et al. MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: A prospective national cohort study. Lancet Neurol 2011;10:1065-1073.
4. Quintana FJ, Hagedorn PH, ElizurG, Merbl Y, Domany E, Cohen IR. Functional immunomics: microarray analysis of IgG autoantibody repertoires predicts the future response of mice to induced diabetes. Proc Natl Acad Sci USA 2004;101 (suppl 2):14615-14621.
5. Robinson WH, Digennaro C, Hueber W, et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med 2002;8:295-301.
6. Bar-Or A, Vollmer T, Antel J, et al. Induction of antigenspecific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial. Arch Neurol 2007;64: 1407-1415.
7. Garren H, Robinson WH, Krasulová E, et al. Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis. Ann Neurol 2008;63:611-620.
8. Kanter JL, Narayana S, Ho PP, et al. Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat Med 2006;12:138-143.
9. Quintana FJ, Farez MF, Izquierdo G, Lucas M, Cohen IR, Weiner HL. Antigen microarrays identify CNS-produced autoantibodies in RRMS. Neurology 2012;78:532-539.
10. Quintana FJ, Farez MF, Viglietta V, et al. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc Natl Acad Sci U S A 2008;105:18889-18894.
11. Quintana FJ, Basso AS, Iglesias AH, et al. Control of T (reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008;453:65-71.
12. Robinson WH, Fontoura P, Lee BJ, et al. Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat Biotechnol 2003;21:1033-1039.
13. Banwell B, Bar-Or A, Arnold DL, et al. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: A prospective national cohort study. Lancet Neurol 2011;10:436-445.
14. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann Neurol 2005;58:840-846.
15. De Jager PL, Chibnik LB, Cui J, et al. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: A weighted genetic risk score. Lancet Neurol 2009;8:1111-1119.
16. Probstel AK, Dornmair K, Bittner R, et al. Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 2011;77:580-588.
17. Lehmann PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992;358:155-157.
18. Vanderlugt CL, Miller SD. Epitope spreading in immunemediated diseases: implications for immunotherapy. Nat Rev Immunol 2002;2:85-95.
19. Goebels N, Hofstetter H, Schmidt S, Brunner C, Wekerle H, Hohlfeld R. Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: epitope spreading versus clonal persistence. Brain 2000;123:508-518.
20. Bailey SL, Schreiner B, Mcmahon EJ, Miller SD. CNS myeloid DCs presenting endogenous myelin peptides "preferentially" polarize CD41 TH-17 cells in relapsing EAE. Nat Immunol 2007;8:172-180.
21. Mcmahon EJ, Bailey SL, Castenada CV, Waldner H, Miller SD. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat Med 2005; 11:335-339.
22. Astier AL, Meiffren G, Freeman S, Hafler DA. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J Clin Invest 2006;116: 3252-3257.
23. Balint B, Haas J, Schwarz A, et al. T-cell homeostasis in pediatric multiple sclerosis: old cells in young patients. Neurology 2013;81:784-792.
24. Viglietta V. Loss of functional suppression by CD41CD251 regulatory T cells in patients with multiple sclerosis. J Exp Med 2004;199:971-979.
25. Venken K, Hellings N, Hensen K, et al. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD41CD251 regulatory T-cell function and FOXP3 expression. J Neurosci Res 2006;83: 1432-1446.
26. Dhaunchak AS, Becker C, Schulman H, et al. Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis. Ann Neurol 2012;71:601-613.
27. Quintana FJ, Murugaiyan G, Farez MF, et al. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2010;107: 20768-20773.
28. Yeste A, Nadeau M, Burns EJ, Weiner HL, Quintana FJ. Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2012;109:11270-11275.